Travere Therapeutics, Inc. 2.25% 01-MAR-2029 risks and ratings

Below, we've gathered key metrics for RTRX5376243 risk analysis: see the bond security level, means of inflation protection, issuer rating, and more to evaluate how reliable the RTRX5376243 bonds are and make an informed decision.